Compare ATAI & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATAI | CASH |
|---|---|---|
| Founded | 2018 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2025 | 1996 |
| Metric | ATAI | CASH |
|---|---|---|
| Price | $4.94 | $90.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $15.88 | ★ $107.50 |
| AVG Volume (30 Days) | ★ 10.1M | 206.2K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ 18.88 |
| EPS | N/A | ★ 4.89 |
| Revenue | $4,089,000.00 | ★ $839,894,000.00 |
| Revenue This Year | N/A | $7.56 |
| Revenue Next Year | N/A | $6.02 |
| P/E Ratio | ★ N/A | $18.45 |
| Revenue Growth | ★ 1227.60 | 11.29 |
| 52 Week Low | $2.58 | $65.93 |
| 52 Week High | $6.73 | $101.26 |
| Indicator | ATAI | CASH |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 64.21 |
| Support Level | $3.56 | $87.19 |
| Resistance Level | $5.00 | $94.84 |
| Average True Range (ATR) | 0.43 | 2.27 |
| MACD | 0.03 | 0.45 |
| Stochastic Oscillator | 62.50 | 94.48 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.